Drug Information

Drug General Information
Drug ID
D0L2LQ
Former ID
DNC013805
Drug Name
Allylcarbamic Acid Biphenyl-3-yl Ester
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529498]
Formula
C16H15NO2
Canonical SMILES
C=CCNC(=O)OC1=CC=CC(=C1)C2=CC=CC=C2
InChI
1S/C16H15NO2/c1-2-11-17-16(18)19-15-10-6-9-14(12-15)13-7-4-3-5-8-13/h2-10,12H,1,11H2,(H,17,18)
InChIKey
IVZVLOUIEAWCIN-UHFFFAOYSA-N
PubChem Compound ID
24881608
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529498]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529498J Med Chem. 2008 Jun 26;51(12):3487-98. Epub 2008 May 29.Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.
Ref 529498J Med Chem. 2008 Jun 26;51(12):3487-98. Epub 2008 May 29.Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.